ℹ️
🇬🇧
Search
Search for publications relevant for "TNBC"
TNBC
Publication
Class
Person
Publication
Programmes
Export current view
publication
Treatment strategy of triple negative breast cancer in young women - do we treat them differently?
2023 |
First Faculty of Medicine
publication
Immunotherapy in the treatment of triple negative breast cancer
2022 |
First Faculty of Medicine
publication
Therapeutic options in patients with early breast cancer
2023 |
First Faculty of Medicine
publication
HER-3 molecular classification, expression of PD-L1 and clinical importance in breast cancer
2022 |
First Faculty of Medicine, Third Faculty of Medicine
publication
A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)
2021 |
Publication without faculty affiliation
publication
Sacituzumab govitecan
2022 |
First Faculty of Medicine
publication
Revelation in the treatment of triple-negative breast cancers
2020 |
First Faculty of Medicine
publication
Hereditary breast cancer - an example of uncommon breast cancer in population
2009 |
First Faculty of Medicine
publication
Triple negative breast cancer
2021 |
First Faculty of Medicine
publication
Pokročilý triple negativní karcinom prsu
2017 |
First Faculty of Medicine
publication
Predictive markers in breast cancer
2021 |
First Faculty of Medicine
publication
Breast cancer in young women
2017 |
First Faculty of Medicine, Faculty of Physical Education and Sport
publication
Aktuální možnosti léčby metastazujícího triple negativního karcinomu prsu
2022 |
First Faculty of Medicine
publication
Single-cell protein profiling defines cell populations associated with triple-negative breast cancer aggressiveness
2023 |
Second Faculty of Medicine, Faculty of Science
publication
Clinical importance of her-3 in breast cancer
2020 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer—results from an international, multicenter analysis coordinated by the AGMT Study Group
2023 |
Faculty of Medicine in Pilsen
publication
Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer
2019 |
First Faculty of Medicine
publication
EGFR in triple negative breast carcinoma: significance of protein expression and high gene copy number
2015 |
Faculty of Medicine in Hradec Králové
publication
Morphological and gene-expression characterization of viable heterogeneous circulating tumor cells size-captured and cultured from triple-negative breast cancer mouse models
+1
2016 |
First Faculty of Medicine
publication
Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade
2020 |
Second Faculty of Medicine
publication
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy
2022 |
Faculty of Medicine in Hradec Králové
publication
Clinical and functional importance of selected CASP8 and CASP9 polymorphisms in breast carcinoma
2016 |
First Faculty of Medicine, Central Library of Charles University, Second Faculty of Medicine, Third Faculty of Medicine
publication
Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer
2021 |
Faculty of Medicine in Hradec Králové
publication
Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study
Publication without faculty affiliation
publication
Ixabepilone Alone or With Cetuximab as First-Line Treatment for Advanced/Metastatic Triple-Negative Breast Cancer
2015 |
Publication without faculty affiliation
publication
Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses
2014 |
First Faculty of Medicine
publication
AMACR Expression is a Potential Diagnostic Marker in Apocrine Lesions of Breast, and is Associated with High Histologic Grade and Lymph Node Metastases in Some Invasive Apocrine Breast Cancers
2023 |
First Faculty of Medicine
publication
Characterization of circulating tumor cells in early breast cancer patients receiving neoadjuvant chemotherapy
2021 |
First Faculty of Medicine, Central Library of Charles University